Eukaryotic Cell
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hicks, J. K.
Right arrow Articles by Heitman, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hicks, J. K.
Right arrow Articles by Heitman, J.
Eukaryotic Cell, December 2005, p. 1971-1981, Vol. 4, No. 12
1535-9778/05/$08.00+0     doi:10.1128/EC.4.12.1971-1981.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Pde1 Phosphodiesterase Modulates Cyclic AMP Levels through a Protein Kinase A-Mediated Negative Feedback Loop in Cryptococcus neoformans

Julie K. Hicks,1 Yong-Sun Bahn,1 and Joseph Heitman1,2,3*

Departments of Molecular Genetics and Microbiology,1 Medicine,2 Pharmacology and Cancer Biology,3 Duke University Medical Center, Durham, North Carolina 277104

Received 25 July 2005/ Accepted 20 September 2005


   ABSTRACT
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The virulence of the human pathogenic fungus Cryptococcus neoformans is regulated by a cyclic AMP (cAMP)-dependent protein kinase A (PKA) signaling cascade that promotes mating and the production of melanin and capsule. In this study, genes encoding homologs of the Saccharomyces cerevisiae low- and high-affinity phosphodiesterases, PDE1 and PDE2, respectively, were deleted in serotype A strains of C. neoformans. The resulting mutants exhibited moderately elevated levels of melanin and capsule production relative to the wild type. Epistasis experiments indicate that Pde1 functions downstream of the G{alpha} subunit Gpa1, which initiates cAMP-dependent signaling in response to an extracellular signal. Previous work has shown that the PKA catalytic subunit Pka1 governs cAMP levels via a negative feedback loop. Here we show that a pde1{Delta} pka1{Delta} mutant strain exhibits cAMP levels that are dramatically increased (~15-fold) relative to those in a pka1{Delta} single mutant strain and that a site-directed mutation in a consensus PKA phosphorylation site reduces Pde1 function. These data provide evidence that fluctuations in cAMP levels are modulated by both Pka1-dependent regulation of Pde1 and another target that comprise a robust negative feedback loop to tightly constrain intracellular cAMP levels.


   INTRODUCTION
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
Signal transduction cascades are the primary means by which external cues are communicated to the nuclei of eukaryotic organisms. The resulting changes in gene transcription are manifested as an appropriate response to the given cue. The importance of signal transduction cascades is perhaps best reflected in the high degree of cascade component conservation that exists between animals and fungi, despite the fact that they diverged from a common ancestor over 800 million years ago (29).

In fungi, mitogen-activated protein kinase and cyclic AMP (cAMP)-dependent signal transduction cascades are two major signal transduction conduits. The highly conserved components of the cAMP signaling cascade have been co-opted by many different fungi for a variety of purposes, including regulation of asexual and sexual spore production, mycotoxin production, pseudohyphal growth, mating, pathogenesis, and virulence (1, 16, 17, 20, 32, 36, 42, 48).

The cAMP-dependent signaling pathway has been well characterized for the human-pathogenic basidiomycete fungus Cryptococcus neoformans. Both serotype A (C. neoformans var. grubii) and serotype D (C. neoformans var. neoformans) strains infect immunocompromised individuals and cause meningoencephalitis (6). The virulence of this fungus depends on several factors, including the ability to grow at 37°C and the production of melanin and a polysaccharide capsule (6). Additionally, the ability to mate and grow filamentously also likely has a role in survival and propagation in the environment and may generate infectious propagules (23).

C. neoformans virulence factor production and mating ability are regulated by the cAMP-dependent signaling pathway (for reviews, see references 12 and 29). Components of this pathway that have been identified include a G{alpha} subunit of a heterotrimeric G protein (Gpa1), adenylyl cyclase (Cac1), the PKA catalytic (Pka1 and Pka2) and regulatory (Pkr1) subunits, and an adenylyl cyclase-associated protein (Aca1) that works independently of Gpa1 to activate adenylyl cyclase (1-3, 13, 19) (Fig. 1). Deletion of the GPA1, CAC, or ACA1 gene results in a loss of mating and capsule and melanin production and attenuates virulence. These defects can be rescued by the addition of exogenous cAMP (1-3). Deletion of the Pkr1 regulatory subunit results in increased capsule production and hypervirulence (13). The roles of Pka1 and Pka2 in serotype A and serotype D have diverged. In serotype A, Pka1 plays the primary role in the regulation of mating, capsule and melanin production, and virulence, while Pka2 plays only an ancillary role (3, 13). In serotype D, Pka2 contributes to the regulation of virulence trait production but is not required for virulence (13, 19).



View larger version (27K):
[in this window]
[in a new window]
  		FIG. 1. Model for the role of Pde1 and Pde2 in the cAMP signaling cascade. Virulence factor production is regulated by the cAMP-dependent signaling pathway via the following components: an unidentified seven-transmembrane receptor(s); the G{alpha} subunit (Gpa1); adenylyl cyclase (Cac1) and its associated protein, Aca1; PKA, composed of the Pkr1 regulatory subunit and the Pka1 and Pka2 catalytic subunits; and the PDEase Pde1. In serotype A, the Pka1 catalytic subunit plays a major role in regulating virulence factor production, while the Pka2 subunit plays only a minor role. Intracellular cAMP levels are modulated through a feedback loop controlled by Pka1. When active, Pka1 positively regulates Pde1 and may also negatively regulate Cac1, exerting control over both the production (Cac1) and degradation (Pde1) of cAMP. Although Pde2 has no apparent role in the regulation of intracellular cAMP levels, it is possible that Pde2 may be regulated by Pka2. Solid lines and arrows indicate experimentally proven portions of the pathway, and dashed lines and arrows indicate putative portions of the pathway for which there is, as yet, no experimental evidence. Gray arrows and lines indicate minor roles in the pathway.

 
In Saccharomyces cerevisiae, intracellular cAMP levels are influenced by the activity of the low- and high-affinity phosphodiesterases (PDEases), Pde1 and Pde2, respectively. These phosphodiesterases are structurally distinct, sharing virtually no sequence similarity. Pde2 is a high-affinity PDEase that is represented in organisms ranging from yeast to mammals (7). In contrast, Pde1, the low-affinity PDEase, is less well characterized but is found in a range of organisms, including S. cerevisiae, Schizosaccharomyces pombe, Candida albicans, Dictyostelium discoideum, Vibrio fischeri, Leishmania mexicana, Trypanosoma brucei, and Trypanosoma cruzi (9, 11, 14, 22, 27, 28, 34, 39).

Pde1 and Pde2 have distinct functions. Pde2 regulates basal cAMP levels in both S. cerevisiae and C. albicans (5, 30). Because the regulation of basal cAMP levels is important in determining tolerance to stress, including temperature extremes and high salt and heavy metal concentrations, Pde2 has a pivotal role in stress tolerance (30, 37). In C. albicans, Pde2 is also involved in filamentation, nutrient sensing, entry into stationary phase, and cell wall and membrane integrity (5, 25).

In contrast, S. cerevisiae Pde1 does not significantly affect the basal levels of cAMP and does not confer any obvious mutant phenotype. However, in both S. cerevisiae and S. pombe, Pde1 does regulate cAMP levels induced by the presence of glucose (21, 30). Furthermore, the cAMP degradation activity of Pde1 in S. cerevisiae is positively regulated by the PKA catalytic subunits (35). The regulation of Pde1 activity is also observed in S. pombe, but it is not clear if this regulation is effected directly via PKA catalytic or allosteric activation by cAMP, as occurs in D. discoideum (21, 31). In humans, it has been suggested that some PDEases may be regulated independently of PKA (8).

Here we report the characterization of Pde1 and Pde2 from C. neoformans. We show that, unlike in S. cerevisiae and C. albicans, Pde2 has no apparent role in regulating intracellular cAMP levels, and deletion of the gene results in subtle mutant phenotypes. However, Pde1 clearly is part of the cAMP-dependent signaling pathway that regulates virulence attributes. Not only does Pde1 disruption rescue gpa1{Delta} mutant phenotypes, but we also provide evidence that Pde1 is activated by Pka1 and that it is an important part of the PKA-activated negative feedback loop that governs intracellular cAMP levels in this pathogenic fungus.


   MATERIALS AND METHODS
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
C. neoformans strains and media. All strains used for this study are listed in Table 1. C. neoformans strains were grown on standard S. cerevisiae medium (41). Selective medium for biolistic transformation, Niger seed medium, V8 medium, and Dulbecco's modified Eagle's medium (DMEM) were prepared as described previously (1, 18, 44). For cAMP suppression experiments, cAMP was added at a concentration of 10 mM to the media.


View this table:
[in this window]
[in a new window]
  		TABLE 1. Strains used for this study

 
pka1{Delta}::URA5 transformants were selected on synthetic medium lacking uracil and containing 1 M sorbitol. pde1{Delta}::NAT and pde2{Delta}::NAT transformants were selected on yeast extract-peptone-dextrose (YPD) medium containing 100 µg/ml nourseothricin. pde1{Delta}::NEO and pde2{Delta}::NEO were selected on YPD medium containing 200 µg/ml G418. Genotypes were confirmed by both Southern hybridization and expression analysis.

Identification of C. neoformans PDE1 and PDE2 genes. The C. neoformans PDE1 and PDE2 genes were identified in serotype A and D strains by performing a tBLASTn search of the Duke Bioinformatics C. neoformans serotype A database (http://cneo.genetics.duke.edu/menu.html) and the Stanford Genome Technology Center serotype D database (http://www-sequence.stanford.edu/group/C.neoformans/overview.html), using the S. cerevisiae Pde1 and Pde2 protein sequences.

Disruption of PKA1, PDE1, and PDE2 genes. The pka1{Delta}, pde1{Delta}, and pde2{Delta} null mutants were generated by overlap PCR as described previously (10). The primer sequences used for this study are available upon request. To construct the pka1{Delta}::URA5 allele, in the first round of PCR the 5' end of the PKA1 gene was amplified with primers 9352 and 9354, the 3' end of the gene was amplified with primers 9355 and 9357, and the URA5 gene was amplified with primers 9352 and 9356. Primers 9352 and 9357 were then used in an overlap amplification with the first three products as templates to yield the ~4.0-kb PCR product bearing the pka1{Delta}::URA5 allele. The gel-extracted PKA1 disruption cassette was precipitated onto 0.6-µg gold microcarrier beads (0.8-µm; Bioworld Inc.) and transformed into the MAT{alpha} ura5 serotype A strain F99 by biolistic transformation (44). The pka1{Delta}::URA5 allele deletes the entire PKA1 open reading frame (ORF).

The PDE1 and PDE2 gene ORFs were disrupted by biolistic transformation of the congenic C. neoformans serotype A strains H99 and KN99a with constructs generated by overlap PCR (10). The 5' and 3' regions of the PDE1 and PDE2 genes in serotype A strains were PCR amplified with the following primers: 10403/10404 and 10347/10348 for the 5' regions of the PDE1 and PDE2 genes, respectively, and 10405/10406 and 10349/10350 for the 3' regions of PDE1 and PDE2, respectively. M13F and M13R primers were used to generate Natr dominant selectable markers from the template pNATSTM#58 (for PDE1) or pNATSTM#102 (for PDE2), with a unique signature tag (33), and Neor dominant selectable markers from the template pJAF1 (15). The PDE1 disruption alleles were generated by overlap PCR using primers 10403 and 10406. The PDE2 disruption alleles were generated by overlap PCR using primers 10347 and 10350. Prototrophic wild-type strains were biolistically transformed with the gel-extracted PDE1 and PDE2 disruption alleles as described previously (10). pde1{Delta} and pde2{Delta} strains were screened by diagnostic PCR for the 5' and 3' junctions and by Southern blot analysis using specific probes generated by PCR with the primers 10423/10424 and 11206/11207 for the PDE1 and PDE2 genes, respectively (data not shown).

Complementation of the pde1{Delta} mutant. The serotype A PDE1 gene for complementation of the pde1{Delta} mutant was amplified via PCR using primers 13458 and 13459, with wild-type (H99) genomic DNA as the template. This ~3.8-kb product included the promoter, ORF, and terminator regions of the PDE1 gene and was initially cloned into the pCR2.1-TOPO vector (Invitrogen), creating plasmid pJH106. pJH106 was digested with ApaI and NotI, and the fragment was ligated into pJAF12 (3), creating plasmid pJH108. Strain JKH173 was transformed with plasmid pJH108, using the biolistic apparatus (44).

Site-directed mutagenesis. To mutate the putative PKA phosphorylation site in Pde1, we constructed plasmid pJH168, containing the pde1S226A mutation, via overlap PCR (10). An ~1.3-kb SalI fragment comprising the PDE1 sequence containing a mutation in the sole putative PKA phosphorylation site was created by first amplifying the regions upstream of the putative phosphorylation site (primers 14506 and 14509) and downstream of the site (primers 14507 and 14508). The pde1S226A allele was generated by overlap PCR with primers 14506 and 14507. This fragment was cloned into the pCR2.1-TOPO vector (Invitrogen) to create plasmid pJH155 and sequenced. pJH108 was digested with SalI, and the wild-type 1.3-kb fragment was replaced with the pde1S226A-containing 1.3-kb SalI fragment from pJH155 to create plasmid pJH168. Strains JKH238 and JKH271, containing the pde1S226A mutation, were generated by biolistically transforming plasmid pJH168 into strains JKH173 and JKH95, respectively. The presence of the mutated allele in strains JKH238 and JKH271 was further confirmed by PCR amplification and sequencing of the relevant region.

Expression analysis. Fungal strains were inoculated into 5 ml YPD medium and grown overnight at 30°C. Fifty milliliters of YPD medium in a 125-ml flask was inoculated with 500 µl of overnight culture and grown at 250 rpm and 30°C for 5 h prior to harvesting. RNAs were isolated from the harvested cultures with Trizol (Gibco-BRL) according to the manufacturer's instructions. Fifteen micrograms (as indicated by spectrophotometric measurement) of RNA was separated in a denaturing gel and transferred to a nylon membrane. The resulting blots were probed with PDE1 and PDE2 gene-specific probes.

Capsule assays. To assess capsule and cell sizes, each strain was inoculated onto a plate of DMEM and grown at either 30°C (see Fig. 3) or 37°C (see Fig. 4 and 6) for 2 days. Aliquots of all cultures were stained with India ink and viewed with a 100x oil objective. Twenty cells from each culture were chosen at random, and the cell and capsule sizes were measured using Axiovision 3.0 software (Carl Zeiss Microscopy). The relative capsule diameter was calculated with the following equation: (Dw – Dc) x 100/Dw, where Dw and Dc indicate the diameters of the whole-cell body (Dw; cell plus capsule) and the cell body only (Dc) (49). The Bonferroni multiple comparison test was performed with Prism 4.0 software (GraphPad Software) to compare each strain to every other strain (3, 49). Each experiment was done in triplicate (total n = 60).



View larger version (34K):
[in this window]
[in a new window]
  		FIG. 3. Deletion of the PDE1 and PDE2 genes causes modest increases in melanin and capsule production. (A) Serotype A wild-type (H99) and pde1{Delta} (JKH63), pde2{Delta} (JKH33), and pde1{Delta} pde2{Delta} (JKH70) mutant strains were grown on Niger seed agar, with or without 10 mM cAMP, and incubated for 2 days at 37°C prior to being photographed. Melanin production was not obviously different in any of the mutant strains relative to the wild-type strain. (B) Melanin production in serotype A strains was quantitated by growing wild-type (H99) and pde1{Delta} (JKH63), pde2{Delta} (JKH33), pde1{Delta} pde2{Delta} (JKH70), and lac1{Delta} (CHM3) mutant strains at 250 rpm and 30°C for 16 h in L-DOPA medium, with or without 10 mM cAMP, prior to transferring cultures to 250 rpm and 25°C for 24 h. Spectrophotometric readings of the culture supernatants were taken to determine the OD475. One unit of laccase is equal to an OD475 of 0.001 (50). Each bar represents an average of five independent replicates. Standard deviations are indicated by error bars. (C) Serotype A wild-type (H99) and pde1{Delta} (JKH63), pde2{Delta} (JKH33), and pde1{Delta} pde2{Delta} (JKH70) mutant strains were inoculated onto agar-based DMEM (18), with or without 10 mM cAMP, incubated at 30°C for 2 days, and examined by the exclusion of India ink (magnification, x1,000). (D) Quantitative measurements of relative capsule diameters (see Materials and Methods). A total of 60 cells (20 cells from three independent experiments) were measured for each strain, and error bars indicate standard deviations.

 


View larger version (41K):
[in this window]
[in a new window]
  		FIG.4. pde1{Delta} mutation restores mating and melanin and capsule production of gpa1{Delta} mutants. (A) Serotype A wild-type (H99), gpa1{Delta} (YSB83), pde1{Delta} gpa1{Delta} (JKH111), pde2{Delta} gpa1{Delta} (JKH101), pde1{Delta} pde2{Delta} gpa1{Delta} (JKH116), pde1{Delta} (JKH63), pde2{Delta} (JKH33), and pde1{Delta} pde2{Delta} (JKH70) mutant, and pde1{Delta} gpa1{Delta} PDE1 complemented strains were grown on Niger seed agar and incubated for 2 days at 37°C prior to being photographed. (B) The strains used for panel A were grown in YPD overnight prior to being plated onto agar-based DMEM, incubated for 2 days at 37°C, resuspended in ddH2O, stained with India ink, and photographed at a magnification of x1,000. (C) For each strain used for panels A and B, a total of 60 cells (20 cells from three independent experiments) were treated as described in panel B and then measured (see Materials and Methods). Error bars indicate standard deviations. (D) MAT{alpha} and MATa strains were cocultured on V8 (pH 5.0) medium and incubated at room temperature for 14 days in the dark prior to being photographed (magnification, x100). These strains included {alpha} x a (H99 x KN99a), gpa1{Delta} x a (YSB83 x KN99a), pde1{Delta} gpa1{Delta} x a (JKH111 x KN99a), pde2{Delta} gpa1{Delta} x a (JKH101 x H99), pde1{Delta} pde2{Delta} gpa1{Delta} x a (JKH116 x H99), and pde1{Delta} gpa1{Delta} PDE1 x a (JKH190 x H99). (E) Intracellular cAMP levels were measured in each of the strains used for panels A to C.

 


View larger version (55K):
[in this window]
[in a new window]
  		FIG. 6. Elimination of a PKA phosphorylation site results in a loss of Pde1 activity and increased cAMP levels in a pka1{Delta} background. Site-directed mutagenesis was utilized to eliminate the single PKA phosphorylation site in Pde1 (pde1S226A). The mutant PDE1 alleles were introduced into the pde1{Delta} gpa1{Delta} background, and the resultant pde1{Delta} gpa1{Delta} pde1S226A (JKH238) strain was compared with the wild-type strain (H99) and the gpa1{Delta} (YSB83), pde1{Delta} (JKH63), pde1{Delta} gpa1{Delta} (JKH173), and pde1{Delta} gpa1{Delta} PDE1 (JKH190) mutant strains. Melanin (A) and capsule (B) production were examined as described in Materials and Methods. Cultures for examinations of capsule production were incubated at 37°C for 2 days prior to being observed by India ink staining. Bar, 10 µm. (C) cAMP levels were also examined as described in Materials and Methods. The pde1{Delta} pka1{Delta} and pde1{Delta} pka1{Delta} pde1S226A strains produced significantly higher levels of cAMP than any of the other strains, and the pka1{Delta} strain also had levels higher than those of the wild type or the pde1{Delta} mutant; the scale for the data shown in the graph on the left was expanded to illustrate this.

 
Laccase assays. To quantitate melanin production, the wild-type (H99) and pde1{Delta} (JKH63), pde2{Delta} (JKH33), pde1{Delta} pde2{Delta} (JKH70), and lac1{Delta} (CHM3) mutant strains were grown in 25 ml of L-3,4-dihydroxyphenylalanine (L-DOPA) medium (0.1% L-asparagine, 0.1% glucose, 0.3% KH2PO4, 0.01% L-DOPA, 0.025% MgSO4 · 7H2O; pH 5.6) at 30°C and 250 rpm for 16 h. The cultures were then incubated at 25°C and 250 rpm for 24 h, at which time 1 ml of culture was centrifuged, and the supernatant was spectrophotometrically read for the optical density at a wavelength of 475 nm (OD475).

cAMP assays. Examinations of intracellular cAMP levels were performed by growing the wild-type (H99) and pka1{Delta} (JKH7), gpa1{Delta} (YSB83), pde1{Delta} (JKH63), pde2{Delta} (JKH33), pde1{Delta} pde2{Delta} (JKH70), pde1{Delta} pka1{Delta} (JKH95), pde2{Delta} pka1{Delta} (JKH94), pde1{Delta} pde2{Delta} pka1{Delta} (JKH109), pde1{Delta} gpa1{Delta} (JKH111), pde2{Delta} gpa1{Delta} (JKH101), and pde1{Delta} pde2{Delta} gpa1{Delta} (JKH116) mutant strains in 50 ml of YPD medium for 24 h. The cultures were centrifuged and washed twice with double-distilled water (ddH2O) and once with MES buffer (10 mM morpholineethanesulfonic acid [MES; pH 6.0], 0.5 mM EDTA) before being resuspended in MES buffer. Fifteen milliliters of MES buffer was then inoculated in order to give the cultures a final OD600 of 2.0. Following 2 h of incubation at 30°C and 250 rpm, 1-ml samples of each culture were collected via filtration on 0.45-µm filters 0 min, 0.5 min, 1.0 min, and 3.0 min after the addition of 2% glucose. The cell-containing filters were incubated in a petri plate containing 1 ml of formic acid:butanol:ddH2O (3.7:76.3:20) for 1 h prior to transfer of the liquid to a microcentrifuge tube, centrifugation at 13,000 rpm for 10 min, and transfer of the supernatant to a new tube. The resulting liquid was lyophilized, at which time it was resuspended in the assay buffer supplied with the cAMP Biotrak enzyme immunoassay system (Amersham Biosciences). The assay was performed according to the manufacturer's instructions.

Nucleotide sequence accession numbers. The PDE1 and PDE2 serotype A gene sequences have been deposited in the NCBI GenBank database and have the following accession numbers: AY864841 (PDE1A) and AY874131 (PDE2A). The PDE1 and PDE2 gene sequences from serotype D have also been deposited in the NCBI GenBank database and have the following accession numbers: AY864842 (PDE1{Delta}) and AY874132 (PDE2{Delta}).


   RESULTS
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
C. neoformans contains homologs of low- and high-affinity PDEases, Pde1 and Pde2. S. cerevisiae expresses two PDEases, the low-affinity form, Pde1, and the high-affinity form, Pde2. Pde1 functions in response to agonist-induced increases in cAMP, while Pde2 regulates basal cAMP levels (30). Using the S. cerevisiae Pde1 and Pde2 protein sequences, we performed a tBLASTn search to identify C. neoformans serotype A and serotype D Pde1 and Pde2 homologs. One sequence for each protein was identified from each database and designated Pde1 and Pde2. Both Pde1 and Pde2 have the conserved signature sequences for the low- and high-affinity PDEases, respectively (Fig. 2). The serotype A and D Pde1 proteins share 94% identity, and the serotype A and D Pde2 proteins share 93% identity. In contrast, the Pde1 and Pde2 proteins share only 12 to 14% identity, similar to the Pde1 and Pde2 proteins of S. cerevisiae (13% identity).



View larger version (40K):
[in this window]
[in a new window]
  		FIG. 2. C. neoformans Pde1 and Pde2 exhibit signature sequences of low- and high-affinity cAMP PDEases. MacVector software (Accelrys) was used to perform Clustal W comparisons of Pde1 (A) and Pde2 (B). Both proteins contain the conserved signature sequences found in low- and high-affinity homologs, respectively, from S. cerevisiae, S. pombe, and C. albicans. The Pde1 signature sequence is H-x-H-L-D-H-(LIVM)-x-(GS)-(LIVMA)-(LIVM)2-x-S-(AP), and the Pde2 signature sequence is H-D-(LIVMFY)-x-H-x-(AG)-x2-(NQ)-x-(LIVMFY). Only the signature sequences are shown, and the numbers indicate the positions of the sequences in the respective proteins. Accession numbers for the proteins are as follows: CnPde1A, AY864841; CnPde1{Delta}, AY864842; ScPde1, CAA64139; SpPde1, CAA20848; CaPde1, XP720545; CnPde2A, AY874131; CnPde2{Delta}, AY874132; ScPde2, CAA99689; CaPde2, AAM89252.

 
Deletion of PDE1 and PDE2 enhances melanin and capsule production. The entire ORFs of the PDE1 and PDE2 genes were deleted from a serotype A wild-type strain to examine their role in the production of virulence factors. Expression analysis confirmed that the entire ORF had been deleted in both cases (data not shown). The wild-type strain and the pde1{Delta}, pde2{Delta}, and pde1{Delta} pde2{Delta} mutant strains were inoculated on Niger seed agar (1) and incubated at 37°C for 2 days to examine melanin production. This qualitative assay did not reveal any obvious differences between the mutant strains and the wild type (Fig. 3A). Nevertheless, a quantitative analysis of laccase production in L-DOPA medium (19) showed that the laccase activities of the mutants were increased relative to that of the wild-type strain (Fig. 3B). When 10 mM exogenous cAMP was added, all strains exhibited laccase activities that were indistinguishable from each other (Fig. 3B). The lac1{Delta} control strain, in which the LAC1 laccase gene has been eliminated, exhibited essentially no laccase activity in the presence or absence of exogenous cAMP.

To examine the capsule, the wild-type and mutant strains were inoculated onto DMEM (18) and incubated at 37°C for 2 days. By visual observation and quantitative analysis, capsule production by the mutant strains was modestly enhanced relative to that of the wild type (Fig. 3C and D).

The mating ability of the pde1{Delta} and pde2{Delta} mutants was also examined, but no apparent mutant phenotype was observed (data not shown).

The pde1{Delta} mutation restores virulence trait production in a gpa1{Delta} mutant. We next examined if, like Pde1 and Pde2 in S. cerevisiae, the C. neoformans Pde1 and/or Pde2 protein functions in the cAMP-dependent PKA signaling pathway (reviewed in reference 12). Gpa1 is the G{alpha} subunit that functions early in this pathway, and deletion of GPA1 compromises melanin and capsule production and reduces mating (1, 3). Additionally, gpa1{Delta} mutants have low basal cAMP levels relative to wild-type strains. We hypothesized that if Pde1 and/or Pde2 functions downstream of Gpa1, then in epistasis analysis gpa1{Delta} mutant strains also containing either the pde1{Delta} or pde2{Delta} mutation should have higher levels of cAMP than the gpa1{Delta} single mutant, and these elevated cAMP levels might suffice to suppress gpa1{Delta} mutant phenotypes. This hypothesis was based on the assumption that deletion of PDE1 and/or PDE2 would result in a loss of PDEase activity and thereby reduce the degradation of even the basal levels of cAMP present in the gpa1{Delta} strain.

To perform epistasis analysis, pde1{Delta} gpa1{Delta}, pde2{Delta} gpa1{Delta}, and pde1{Delta} pde2{Delta} gpa1{Delta} mutant strains were generated via meiotic crosses in a serotype A background. These strains were then inoculated onto Niger seed agar and DMEM to examine melanin and capsule production, respectively. Additionally, each mutant strain was mated with a wild-type strain, and relative mating abilities were determined by visualizing filament production. Melanin production by the gpa1{Delta} mutant was fully rescued by the pde1{Delta} mutation, but not by the pde2{Delta} mutation (Fig. 4A), and mating ability was also partially restored by the pde1{Delta} but not the pde2{Delta} mutation (Fig. 4D). The capsule production of gpa1{Delta} mutant cells was clearly rescued by the pde1{Delta} mutant and may have been modestly rescued by the pde2{Delta} mutation (Fig. 4B and C). The wild-type PDE1 gene complemented the pde1{Delta} mutation when a pde1{Delta} gpa1{Delta} strain was transformed with the wild-type PDE1 gene. The resulting complemented strain (pde1{Delta} gpa1{Delta} PDE1) exhibited melanin, capsule, and mating defects similar to those of the gpa1{Delta} single mutant (Fig. 4A, C, and D).

To determine if the observed phenotypes of the pde1{Delta} gpa1{Delta} and pde2{Delta} gpa1{Delta} double mutant strains and the pde1{Delta} pde2{Delta} gpa1{Delta} triple mutant strain are correlated with intracellular cAMP levels, cAMP assays were performed on samples collected after glucose induction. As previously reported (2, 3), wild-type cAMP levels increased rapidly following the addition of glucose to glucose-starved cells, and gpa1{Delta} mutants failed to mount a cAMP increase in response to glucose (Fig. 4E). A similar increase was also observed for the pde1{Delta} strain, and although the error in the measurements was large, there was a trend towards higher cAMP levels than those in the wild type. Consistent with the results of epistasis analysis, the pde1{Delta} mutation enhanced cAMP levels in the pde1{Delta} gpa1{Delta} mutant, and glucose clearly enhanced cAMP production in the pde1{Delta} pde2{Delta} gpa1{Delta} mutant strain (Fig. 4E).

Intracellular cAMP levels are elevated in a pde1{Delta} background. In S. cerevisiae, the PKA catalytic subunits regulate cAMP levels through a negative feedback loop in which Pde1 is activated by PKA phosphorylation (30). Pka1, the C. neoformans PKA catalytic subunit, also negatively regulates cAMP levels, but the regulatory mechanism was not known (13). We tested whether this negative feedback loop involves a positive regulation of Pde1 by Pka1.

Previous work has shown that pka1{Delta} mutants have elevated intracellular cAMP levels relative to a wild-type strain (13). One plausible model is that activated Pka1 normally activates Pde1, resulting in cAMP degradation, whereas the pka1{Delta} mutant is unable to activate Pde1. It is also possible that Pka1 has other targets in addition to Pde1 as part of the regulation it imposes on cAMP levels (35). Also, Pde1 may be subject to both Pka1-dependent and -independent regulation (8), allowing for a minimal degradation of cAMP even in the absence of a functional Pka1. In either scenario, pde1{Delta} pka1{Delta} mutants may have elevated cAMP levels relative to the pka1{Delta} mutant. To test this, intracellular cAMP levels were measured during glucose sensing (Fig. 5).



View larger version (24K):
[in this window]
[in a new window]
  		FIG. 5. pde1{Delta} mutation results in highly elevated intracellular cAMP levels in a pka1{Delta} background. Intracellular cAMP levels were measured in a serotype A wild-type (H99) strain and the pka1{Delta} (JKH7), pde1{Delta} pka1{Delta} (JKH95), pde2{Delta} pka1{Delta} (JKH94), pde1{Delta} pde2{Delta} pka1{Delta} (JKH109), pde1{Delta} (JKH63), pde2{Delta} (JKH33), and pde1{Delta} pde2{Delta} (JKH70) mutant strains. The pde1{Delta} pka1{Delta} and pde1{Delta} pde2{Delta} pka1{Delta} strains produced significantly higher levels of cAMP than any of the other strains, and the scale for the data shown in panel A was expanded to illustrate this (B). The pka1{Delta} and pde2{Delta} pka1{Delta} strains had levels higher than those of the other strains, and the scale for the data in panel B was expanded to show this (C).

 
The wild-type strain and the pde1{Delta}, pde2{Delta}, and pde1{Delta} pde2{Delta} mutant strains all showed similarly elevated cAMP levels in response to glucose (Fig. 5C). The pka1{Delta} mutant had cAMP levels that were significantly higher (~50-fold) than those in the wild-type strain and the pde1{Delta}, pde2{Delta}, and pde1{Delta} pde2{Delta} mutant strains (Fig. 5B), as expected based on its established role in a negative feedback loop (13, 46). The pde1{Delta} pka1{Delta} mutant exhibited cAMP levels that were approximately 10 times higher than those found in the pka1{Delta} single mutant strain and ~500-fold higher than those in the wild-type strain (Fig. 5A), indicating that Pde1 plays a significant role in constraining cAMP levels, even in the absence of Pka1. These data also suggest that Pka1 has additional targets besides Pde1, because the phenotype conferred by the pka1{Delta} mutation on cAMP levels is exerted even in the absence of Pde1 (compare the pde1{Delta} mutant and the pde1{Delta} pka1{Delta} mutant in Fig. 5). Also, these data provide further support that Pde2 plays only a minor role, if any, in regulating cAMP levels.

Elimination of a PKA phosphorylation site causes a loss of Pde1 function. The S. cerevisiae Pde1 enzyme has one consensus PKA phosphorylation site [(K/R)-(K/R)-(X)-(S/T)] (26). Mutagenesis of the serine residue in this site (pde1S252A) results in reduced Pde1 activity (30). To determine if Pka1 phosphorylates and subsequently activates Pde1 in C. neoformans, we examined the Pde1 sequence for putative PKA phosphorylation sites, using the PROSCAN site/signature sequence recognition program, and found that the serotype A Pde1 protein contains one putative PKA phosphorylation site (RKKS). We predicted that if Pka1 activates Pde1 by phosphorylation of the serine residue in this site, then mutagenesis of the serine to an alanine would result in a Pde1 protein that was unable to be activated and would hence act as a pde1{Delta} allele.

To test this hypothesis, we generated a PDE1 allele identical to the construct that was utilized to complement the pde1{Delta} mutation in a gpa1{Delta} background, except for an S226A mutation at the serine residue in the putative PKA phosphorylation site. Both the pde1{Delta} gpa1{Delta} strain and the pde1{Delta} pka1{Delta} strain were transformed with the pde1S226A allele. Northern analysis indicated that the pde1S226A transcript level was comparable to that of the wild-type PDE1 gene, although this does not exclude the possibility that the resulting phenotypes could be attributable to a loss of function or instability of the pde1S226A protein. The pde1{Delta} gpa1{Delta} pde1S226A transformant was examined for the ability to produce melanin and capsule. As predicted if the pde1S226A allele acts as a pde1 null mutant, melanin and capsule production in the pde1{Delta} gpa1{Delta} pde1S226A strain was indistinguishable from that in the pde1{Delta} gpa1{Delta} mutant (Fig. 6A and B). This is in contrast to the pde1{Delta} gpa1{Delta} PDE1-complemented strain, in which the melanin and capsule defects conferred by the gpa1{Delta} mutation were readily apparent. When the pde1S226A allele was placed in a pde1{Delta} pka1{Delta} background, cAMP levels were elevated similarly to the levels found in a pde1{Delta} pka1{Delta} mutant (Fig. 6C), again suggesting that the pde1S226A allele acts like a pde1{Delta} null mutant.


   DISCUSSION
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
Cyclic AMP signaling plays multiple roles in regulating development in eukaryotic organisms as diverse as slime molds, fungi, and humans. Here we define the PDE1 and PDE2 genes in the basidiomycete fungus C. neoformans and their biological function in cAMP signaling. Although similar to proteins in the divergent fungal model S. cerevisiae in some aspects, both the Pde1 and Pde2 proteins also show functional distinctions from their S. cerevisiae counterparts. The PDE1 gene encodes a phosphodiesterase protein that has a significant role in regulating cAMP levels in the cell. For S. cerevisiae, it has been determined that Pde1 is responsible for regulating agonist-induced cAMP levels, based on cAMP assays showing that the initial, transient spike in cAMP levels that occurs after glucose addition was enhanced in a pde1{Delta} mutant (30). In the C. neoformans pde1{Delta} mutant, only a modest enhancement of cAMP levels was observed upon glucose induction. Pde1 may be regulated through other pathways in addition to the cAMP-dependent signaling pathway (Fig. 1) (8), a hypothesis supported by our observation that in a pde1{Delta} pka1{Delta} mutant, cAMP levels are much higher than in a pka1{Delta} single mutant, suggesting that Pka1-independent regulation of Pde1 may occur such that in a pka1{Delta} mutant there is still some activity of Pde1 allowing for cAMP degradation. Also, it is possible that the feedback inhibition of cAMP levels initiated by Pka1 (see below) is robust enough that cAMP levels do not escalate substantially when Pde1 is absent.

Deletion of the PDE1 gene by itself conferred only modest increases in melanin and capsule production in otherwise wild-type cells. However, deletion of PDE1 in combination with mutation of the G{alpha} subunit Gpa1 remediated the melanin, capsule, and mating defects caused by the gpa1{Delta} single mutation. cAMP assays showed significantly higher cAMP levels in a pde1{Delta} gpa1{Delta} double mutant than in a gpa1{Delta} single mutant, supporting a model in which the deletion of PDE1 in a gpa1{Delta} background results in cAMP levels that are sufficient to substantially activate the protein kinase catalytic subunit Pka1. The observation that the pde1{Delta} pde2{Delta} gpa1{Delta} mutant strain responded to glucose in the absence of a functional G{alpha} subunit suggests that this response is independent of the G-protein-coupled receptor. As in S. cerevisiae, it is possible that C. neoformans is able to sense intracellular glucose levels, possibly as the metabolite glucose-6-phosphate (40), but that intracellular glucose levels stimulate cAMP to such a low extent that only in the absence of one or both phosphodiesterases is the increase in cAMP levels detectable.

Previous studies have shown that in C. neoformans, activated Pka1 mediates a negative feedback loop that controls intracellular cAMP levels (13, 46). However, the mechanism for this regulation had not been elucidated. S. pombe also exhibits negative feedback regulation of cAMP levels, and it has been established that Pde1 is part of this regulatory network, although the relationship between Pde1 and the PKA catalytic subunit Pka1 is not clear (21). In contrast, for S. cerevisiae it has been definitively shown that the PKA catalytic subunits phosphorylate serine residue 252 in Pde1, causing the activation and subsequent degradation of cAMP. Site-directed mutagenesis of this residue to create a pde1S252A allele resulted in decreased Pde1 activity in vitro (30). Our data suggest that a similar situation to that in S. cerevisiae exists in C. neoformans. A single putative PKA phosphorylation site was found in Pde1, at residues 223 to 226. A site-directed mutation (pde1S226A) in the serine residue of this putative phosphorylation site reduced the protein activity of Pde1. Additionally, both the pde1{Delta} pka1{Delta} mutant and the pde1{Delta} pka1{Delta} pde1S226A mutant had cAMP levels that were elevated relative to that in the pka1{Delta} single mutant. This suggests that Pde1 is activated independently of Pka1, in addition to Pka1-dependent regulation, and that Pka1 targets other proteins in addition to Pde1 as part of the negative feedback loop that modulates intracellular cAMP levels (Fig. 1).

Additional candidate targets of Pka1 include proteins upstream of Pka1 in the cAMP-dependent signaling pathway, such as the Pkr1 protein kinase A regulatory subunit and the Cac1 adenylyl cyclase protein homologs from divergent C. neoformans serotypes, which both have putative conserved PKA phosphorylation sites. In S. cerevisiae, the Bcy1 PKA regulatory subunit is not thought to be a candidate for additional feedback regulation, while the Cyr1 adenylyl cyclase is (43). In S. pombe, cAMP levels are controlled by the regulation of both adenylyl cyclase and the Pde1 homolog, Cgs2 (21). Studies with S. pombe suggest that shortly after the glucose-stimulated activation of adenylyl cyclase, the Cgs2 phosphodiesterase is also activated, resulting in a modulation of cAMP levels (45). Site-directed mutagenesis of the sites in the C. neoformans Cac1 and Pkr1 proteins should elucidate whether these candidate proteins are targets of Pka1 and if they have roles in the negative feedback loop that regulates cAMP levels in C. neoformans.

The role of Pde2 in regulating cAMP (30) production is less obvious than that of Pde1. Pde2 contains the class I signature sequence found in numerous high-affinity PDEase proteins, and RNA analysis confirmed that a transcript was produced. However, deletion of the PDE2 gene has only modest effects on mating or melanin or capsule production, does not result in a significant change from the wild-type strain with regard to cAMP levels, and results in no change in heat shock or oxidative stress resistance. Pde2 regulates heat shock sensitivity in S. cerevisiae (30); that it does not in C. neoformans supports other evidence that the cAMP signaling pathway is not as involved in the response to environmental stresses as it is in other fungi (24). We noted that the pde2{Delta} mutation appears to weakly rescue capsule production in a gpa1{Delta} strain (Fig. 4A) and thus might function under some more limited physiological contexts, in contrast to Pde1. These data suggest that Pde2 either is not in the same signaling pathway as Gpa1, does not function similarly to Pde1, or is not regulated in the same manner as Pde1.

It is probable that C. neoformans contains two related but distinct feedback regulation systems controlling the cAMP pathway, one involving cAMP degradation (via induction of the Pde1 phosphodiesterase) and another involving cAMP production (via the repression of adenylyl cyclase). This dual regulation suggests that precise regulation of the cAMP pathway may be critical to the maintenance of virulence attributes of the pathogen. The fact that several other fungi, including the nonpathogenic organisms S. cerevisiae and S. pombe, share this regulatory network supports the contention that the constraint of intracellular cAMP levels is critical for cellular function in many organisms. Therefore, future studies of C. neoformans will investigate the impact of this strict constraint on the cAMP pathway in fungal survival and virulence during the course of disease.


   ACKNOWLEDGMENTS
 
We thank Xiaorong Lin, Jeffrey Batten, Chaoyang Xue, and Alex Idnurm for helpful suggestions in the preparation of the manuscript.

This research was funded in part by an NIH interdisciplinary AIDS training grant (AI07392-14) (J.K.H.) and by RO1 grant AI39115 and PO1 grant AI44975 (J.H.).


   FOOTNOTES
 
* Corresponding author. Mailing address: Department of Molecular Genetics and Microbiology, 322 CARL Bldg., Duke University Medical Center, Research Dr., Durham, NC 27710. Phone: (919) 684-2824. Fax: (919) 684-5458. E-mail: heitm001{at}duke.edu. Back


   REFERENCES
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Alspaugh, J. A., J. R. Perfect, and J. Heitman. 1997. Cryptococcus neoformans mating and virulence are regulated by the G-protein {alpha} subunit GPA1 and cAMP. Genes Dev. 11:3206-3217.[Abstract/Free Full Text]
  2. Alspaugh, J. A., R. Pukkila-Worley, T. Harashima, L. M. Cavallo, D. Funnell, G. M. Cox, J. R. Perfect, J. W. Kronstad, and J. Heitman. 2002. Adenylyl cyclase functions downstream of the G{alpha} protein Gpa1 and controls mating and pathogenicity of Cryptococcus neoformans. Eukaryot. Cell 1:75-84.[Abstract/Free Full Text]
  3. Bahn, Y. S., J. K. Hicks, S. S. Giles, G. M. Cox, and J. Heitman. 2004. Adenylyl cyclase-associated protein Aca1 regulates virulence and differentiation of Cryptococcus neoformans via the cyclic AMP-protein kinase A cascade. Eukaryot. Cell 3:1476-1491.[Abstract/Free Full Text]
  4. Bahn, Y. S., K. Kojima, G. M. Cox, and J. Heitman. 2005. Specialization of the HOG pathway and its impact on differentiation and virulence of Cryptococcus neoformans. Mol. Biol. Cell 16:2285-2300.[Abstract/Free Full Text]
  5. Bahn, Y. S., J. Staab, and P. Sundstrom. 2003. Increased high-affinity phosphodiesterase PDE2 gene expression in germ tubes counteracts CAP1-dependent synthesis of cyclic AMP, limits hypha production and promotes virulence of Candida albicans. Mol. Microbiol. 50:391-409.[CrossRef][Medline]
  6. Casadevall, A., and J. R. Perfect. 1998. Cryptococcus neoformans. ASM Press, Washington, D.C.
  7. Charbonneau, H., N. Beier, K. A. Walsh, and J. A. Beavo. 1986. Identification of a conserved domain among cyclic nucleotide phosphodiesterases from diverse species. Proc. Natl. Acad. Sci. USA 83:9308-9312.[Abstract/Free Full Text]
  8. Conti, M. 2000. Phosphodiesterases and cyclic nucleotide signaling in endocrine cells. Mol. Endocrinol. 14:1317-1327.[Free Full Text]
  9. D'Angelo, M. A., S. Sanguineti, J. M. Reece, L. Birnbaumer, H. N. Torres, and M. M. Flawia. 2004. Identification, characterization and subcellular localization of TcPDE1, a novel cAMP-specific phosphodiesterase from Trypanosoma cruzi. Biochem. J. 378:63-72.[CrossRef][Medline]
  10. Davidson, R. C., J. R. Blankenship, P. R. Kraus, M. D. Berrios, C. M. Hull, C. D'Souza, P. Wang, and J. Heitman. 2002. A PCR-based strategy to generate integrative targeting alleles with large regions of homology. Microbiology 148:2607-2615.[Abstract/Free Full Text]
  11. De Voti, J., G. Seydoux, D. Beach, and M. McLeod. 1991. Interaction between ran1+ protein kinase and cAMP dependent protein kinase as negative regulators of fission yeast meiosis. EMBO J. 10:3759.[Medline]
  12. D'Souza, C., and J. Heitman. 2001. Conserved cAMP signaling cascades regulate fungal development and virulence. FEMS Microbiol. Rev. 25:349-364.[CrossRef][Medline]
  13. D'Souza, C. A., J. A. Alspaugh, C. Yue, T. Harashima, G. M. Cox, J. R. Perfect, and J. Heitman. 2001. Cyclic AMP-dependent protein kinase controls virulence of the fungal pathogen Cryptococcus neoformans. Mol. Cell. Biol. 21:3179-3191.[Abstract/Free Full Text]
  14. Dunlap, P. V., and S. M. Callahan. 1993. Characterization of a periplasmic 3':5'-cyclic nucleotide phosphodiesterase gene, cdpP, from the marine symbiotic bacterium Vibrio fischeri. J. Bacteriol. 175:4615-4624.[Abstract/Free Full Text]
  15. Fraser, J. A., R. L. Subaran, C. B. Nichols, and J. Heitman. 2003. Recapitulation of the sexual cycle of the primary fungal pathogen Cryptococcus neoformans var. gattii: implications for an outbreak on Vancouver Island. Eukaryot. Cell 2:1036-1045.[Abstract/Free Full Text]
  16. Gao, S., and D. L. Nuss. 1996. Distinct roles for two G protein {alpha} subunits in fungal virulence, morphology, and reproduction revealed by targeted gene disruption. Proc. Natl. Acad. Sci. USA 93:14122-14127.[Abstract/Free Full Text]
  17. Gold, S., G. Duncan, K. Barrett, and J. Kronstad. 1994. cAMP regulates morphogenesis in the fungal pathogen Ustilago maydis. Genes Dev. 8:2805-2816.[Abstract/Free Full Text]
  18. Granger, D. L., J. R. Perfect, and D. T. Durack. 1985. Virulence of Cryptococcus neoformans: regulation of capsule synthesis by carbon dioxide. J. Clin. Investig. 76:508-516.
  19. Hicks, J. K., C. A. D'Souza, G. M. Cox, and J. Heitman. 2004. Cyclic-AMP dependent protein kinase catalytic subunits have divergent roles in virulence factor production in two varieties of the fungal pathogen Cryptococcus neoformans. Eukaryot. Cell 3:14-26.[Abstract/Free Full Text]
  20. Hicks, J. K., J. Yu, N. P. Keller, and T. H. Adams. 1997. Aspergillus sporulation and mycotoxin production both require inactivation of the FadA G-protein-dependent signaling pathway. EMBO J. 16:4916-4923.[CrossRef][Medline]
  21. Hoffman, C. S. 2005. Glucose sensing via the protein kinase A pathway in Schizosaccharomyces pombe. Biochem. Soc. Trans. 33:261-264.[CrossRef][Medline]
  22. Hoyer, L. L., L. B. Cieslinski, M. M. McLaughlin, T. J. Torphy, A. R. Shatzman, and G. P. Livi. 1994. A Candida albicans cyclic nucleotide phosphodiesterase: cloning and expression in Saccharomyces cerevisiae and biochemical characterization of the recombinant enzyme. Microbiology 140:1533-1542.[Abstract]
  23. Hull, C. M., and J. Heitman. 2002. Genetics of Cryptococcus neoformans. Annu. Rev. Genet. 36:557-615.[CrossRef][Medline]
  24. Idnurm, A., Y.-S. Bahn, K. Nielsen, X. Lin, J. Fraser, and J. Heitman. 2005. Deciphering the model pathogenic fungus Cryptococcus neoformans. Nat. Rev. Microbiol. 3:753-764.[CrossRef][Medline]
  25. Jung, W. H., P. Warn, E. Ragni, L. Popolo, C. D. Nunn, M. P. Turner, and L. Stateva. 2005. Deletion of PDE2, the gene encoding the high-affinity cAMP phosphodiesterase, results in changes of the cell wall and membrane in Candida albicans. Yeast 22:285-294.[CrossRef][Medline]
  26. Kemp, B. E., and R. B. Pearson. 1990. Protein kinase recognition sequence motifs. Trends Biochem. Sci. 15:342-346.[Medline]
  27. Kunz, S., T. Kloeckner, L.-O. Essen, T. Seebeck, and M. Boshart. 2004. TbPDE1, a novel class I phosphodiesterase of Trypanosoma brucei. Eur. J. Biochem. 271:637-647.[Medline]
  28. Lacombe, M.-L., G. J. Podgorski, J. Franke, and R. H. Kessin. 1986. Molecular cloning and developmental expression of the cyclic nucleotide phosphodiesterase gene of Dictyostelium discoideum. J. Biol. Chem. 261:16811-16817.[Abstract/Free Full Text]
  29. Lengeler, K. B., R. C. Davidson, C. D'Souza, T. Harashima, W.-C. Sheng, P. Wang, X. Pan, M. Waugh, and J. Heitman. 2000. Signal transduction cascades regulating fungal development and virulence. Microbiol. Mol. Biol. Rev. 64:746-785.[Abstract/Free Full Text]
  30. Ma, P., S. Wera, P. V. Dijck, and J. M. Thevelein. 1999. The PDE1-encoded low-affinity phosphodiesterase in the yeast Saccharomyces cerevisiae has a specific function in controlling agonist-induced cAMP signaling. Mol. Biol. Cell 10:91-104.[Abstract/Free Full Text]
  31. Meima, M. E., K. E. Weening, and P. Schaap. 2003. Characterization of a cAMP-stimulated cAMP phosphodiesterase in Dictyostelium discoideum. J. Biol. Chem. 278:14356-14362.[Abstract/Free Full Text]
  32. Mitchell, T. K., and R. A. Dean. 1995. The cAMP-dependent protein kinase catalytic subunit is required for appressorium formation and pathogenesis by the rice blast pathogen Magnaporthe grisea. Plant Cell 7:1869-1878.[Abstract]
  33. Nelson, R. T., J. Hua, B. Pryor, and J. K. Lodge. 2001. Identification of virulence mutants of the fungal pathogen Cryptococcus neoformans using signature-tagged mutagenesis. Genetics 157:935-947.[Abstract/Free Full Text]
  34. Nikawa, J., P. Sass, and M. Wigler. 1987. Cloning and characterization of the low affinity cAMP phosphodiesterase gene of S. cerevisiae. Mol. Cell. Biol. 7:3629-3636.[Abstract/Free Full Text]
  35. Nikawa, J.-I., S. Cameron, T. Toda, K. M. Ferguson, and M. Wigler. 1987. Rigorous feedback control of cAMP levels in Saccharomyces cerevisiae. Genes Dev. 1:931-937.[Abstract/Free Full Text]
  36. Pan, X., and J. Heitman. 1999. Cyclic AMP-dependent protein kinase regulates pseudohyphal differentiation in Saccharomyces cerevisiae. Mol. Cell. Biol. 19:4874-4887.[Abstract/Free Full Text]
  37. Park, J. I., C. M. Grant, and I. W. Dawes. 2005. The high-affinity cAMP phosphodiesterase of Saccharomyces cerevisiae is the major determinant of cAMP levels in stationary phase: involvement of different branches of the Ras-cyclic AMP pathway in stress responses. Biochem. Biophys. Res. Commun. 327:311-319.[CrossRef][Medline]
  38. Perfect, J. R., N. Ketabchi, G. M. Cox, C. W. Ingram, and C. L. Beiser. 1993. Karyotyping of Cryptococcus neoformans as an epidemiological tool. J. Clin. Microbiol. 31:3305-3309.[Abstract/Free Full Text]
  39. Rascon, A., M. E. Viloria, L. De-Chiara, and M. E. Dubra. 2000. Characterization of cyclic AMP phosphodiesterases in Leishmania mexicana and purification of soluble form. Mol. Biochem. Parasitol. 106:283-292.[CrossRef][Medline]
  40. Rolland, F., J. Winderickx, and J. M. Thevelein. 2002. Glucose-sensing and signalling mechanisms in yeast. FEMS Yeast Res. 2:183-201.[Medline]
  41. Sherman, F. 1991. Getting started with yeast. Methods Enzymol. 194:3-21.[CrossRef][Medline]
  42. Sonneborn, A., D. P. Bockmuhl, M. Gerads, K. Kurpanek, D. Sanglard, and J. F. Ernst. 2000. Protein kinase A encoded by TPK2 regulates dimorphism of Candida albicans. Mol. Microbiol. 35:386-396.[CrossRef][Medline]
  43. Thevelein, J. M., and J. H. D. Winde. 1999. Novel sensing mechanisms and targets for the cAMP-protein kinase A pathway in the yeast Saccharomyces cerevisiae. Mol. Microbiol. 33:904-918.[CrossRef][Medline]
  44. Toffaletti, D. L., T. H. Rude, S. A. Johnston, D. T. Durack, and J. R. Perfect. 1993. Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA. J. Bacteriol. 175:1405-1411.[Abstract/Free Full Text]
  45. Wang, L., K. Griffiths, Jr., Y. H. Zhang, F. D. Ivey, and C. S. Hoffman. 2005. Schizosaccharomyces pombe adenylate cyclase suppressor mutations suggest a role for cAMP phosphodiesterase in feedback control of glucose/cAMP signaling. Genetics 10.1534/genetics.105.047233.
  46. Wang, P., G. M. Cox, and J. Heitman. 2004. A Sch9 protein kinase homologue controlling virulence independently of the cAMP pathway in Cryptococcus neoformans. Curr. Genet. 46:247-255.[CrossRef][Medline]
  47. Wang, P., C. B. Nichols, K. B. Lengeler, M. E. Cardenas, G. M. Cox, J. R. Perfect, and J. Heitman. 2002. Mating-type-specific and nonspecific PAK kinases play shared and divergent roles in Cryptococcus neoformans. Eukaryot. Cell 1:257-272.[Abstract/Free Full Text]
  48. Yu, J.-H., J. Wieser, and T. H. Adams. 1996. The Aspergillus FlbA RGS domain protein antagonizes G protein signaling to block proliferation and allow development. EMBO J. 15:5184-5190.[Medline]
  49. Zaragoza, O., B. C. Fries, and A. Casadevall. 2003. Induction of capsule growth in Cryptococcus neoformans by mammalian serum and CO2. Infect. Immun. 71:6155-6164.[Abstract/Free Full Text]
  50. Zhu, X., J. Gibbons, J. Garcia-Rivera, J. Casadevall, and P. R. Williamson. 2001. Laccase of Cryptococcus neoformans is a cell wall-associated virulence factor. Infect. Immun. 69:5589-5596.[Abstract/Free Full Text]

Eukaryotic Cell, December 2005, p. 1971-1981, Vol. 4, No. 12
1535-9778/05/$08.00+0     doi:10.1128/EC.4.12.1971-1981.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow